Samco Mutual FundEquity Schemes - Thematic Fund2.4 years
The scheme seeks to achieve long-term capital appreciation by investing in a portfolio of securities that are involved in special situations such as restructurings, turnarounds, spin-offs, mergers & acquisitions, new trends, new & emerging sectors, digitization, premiumization, and other special corporate actions. These situations often create mispricings and undervalued opportunities that the fund aims to exploit for potential capital appreciation.
Buying brief
Evidence on this desk, framed as a purchase checklist - not SEBI-registered advice.
As of 29 Oct 2026
Stance
Watch before adding
Recent evidence is mixed. Compare peers before increasing exposure.
In three lines
Fits if · Risk-adjusted return (Sharpe) is negative over the available daily history.
Prefer peers if · Prefer 360 ONE QUANT FUND if you want a same-category peer with stronger evidence.
Buy checklist
History depth
Fail
2.4 years - thin for judging consistency.
Engine status
Watch
Recent evidence is mixed. Compare peers before increasing exposure.
Expense ratio
Watch
1.94% TER (Direct). Lower cost compounds on long SIPs.
Drawdown vs peers
Pass
Peak-to-trough -32.2%. Ask whether you can hold through a similar fall.
Vs category
n/a
Category relative read still thin.
Manager tenure
Watch
Vishal Shinde · 0.3 years on the scheme.
Exit load
n/a
No exit-load summary on file.
Tax / wrapper
Pass
Direct Growth, no ELSS lock flagged. Equity LTCG rules still apply after one year - not tax advice.
Portfolio concentration
Pass
Top 10 holdings ≈ 37.9% of the portfolio.
Same-category peers are preloaded into compare when available.
Behaviour and wrappers - the usual India MF failure modes - not a buy instruction.
Drawdown rehearsal
This scheme’s worst fall on file is about 32%. Before you SIP, ask whether you would keep contributing through a similar drop - pausing on fear is the usual India MF failure mode.
SIP discipline
Monitor is recent mixed evidence - keep the SIP unless the buying brief says prefer peers, then swap with intent.
NAV
Path not in current snapshots
n/a
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
SIP XIRR
Equal monthly instalments to latest NAV
Date-aligned against NIFTY 500 TRI. Capture ratios use common month-end observations through 30 Oct 2026.
Peak to trough from a running NAV high, with the path and recovery episodes.
Drawdown
Path not in current snapshots
n/a
31 Jul 2024 – open
Trough 3 Mar 2025 · not recovered
-32.2%
9 Jul 2024 – 29 Jul 2024
Trough 19 Jul 2024 · recovered in 10 days
-4.5%
18 Jun 2024 – 5 Jul 2024
Trough 28 Jun 2024 · recovered in 7 days
-2.3%
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
22
Vs category
76
Consistency
10
Risk-adjusted
1
Drawdown
20
Mean
26
Quantitative engine reasons behind the buying stance. An explanation can only restate what is already here.
Buying stance
Watch before adding
Recent evidence is mixed. Compare peers before increasing exposure.
Why this status
Supporting reads
No supporting reads in the current evidence set.
30 Sept 2026 · 50 holdings · top 10 are 37.9%.
Sterlite Technologies Ltd
Technology
6.5%
Religare Enterprises Ltd
Financial
6.4%
MTAR Technologies Ltd
Industrials
3.9%
Shilpa Medicare Ltd
Healthcare
3.5%
Laurus Labs Ltd
Healthcare
3.3%
Same-category peers with enough history to inspect beside this fund - including tradeoffs.
360 ONE Mutual Fund
Axis Mutual Fund
Bandhan Mutual Fund
Canara Robeco Mutual Fund
HSBC Mutual Fund
Samco Mutual FundEquity Schemes - Thematic Fund2.4 years
The scheme seeks to achieve long-term capital appreciation by investing in a portfolio of securities that are involved in special situations such as restructurings, turnarounds, spin-offs, mergers & acquisitions, new trends, new & emerging sectors, digitization, premiumization, and other special corporate actions. These situations often create mispricings and undervalued opportunities that the fund aims to exploit for potential capital appreciation.
Buying brief
Evidence on this desk, framed as a purchase checklist - not SEBI-registered advice.
As of 29 Oct 2026
Stance
Watch before adding
Recent evidence is mixed. Compare peers before increasing exposure.
In three lines
Fits if · Risk-adjusted return (Sharpe) is negative over the available daily history.
Prefer peers if · Prefer 360 ONE QUANT FUND if you want a same-category peer with stronger evidence.
Buy checklist
History depth
Fail
2.4 years - thin for judging consistency.
Engine status
Watch
Recent evidence is mixed. Compare peers before increasing exposure.
Expense ratio
Watch
1.94% TER (Direct). Lower cost compounds on long SIPs.
Drawdown vs peers
Pass
Peak-to-trough -32.2%. Ask whether you can hold through a similar fall.
Vs category
n/a
Category relative read still thin.
Manager tenure
Watch
Vishal Shinde · 0.3 years on the scheme.
Exit load
n/a
No exit-load summary on file.
Tax / wrapper
Pass
Direct Growth, no ELSS lock flagged. Equity LTCG rules still apply after one year - not tax advice.
Portfolio concentration
Pass
Top 10 holdings ≈ 37.9% of the portfolio.
Same-category peers are preloaded into compare when available.
Behaviour and wrappers - the usual India MF failure modes - not a buy instruction.
Drawdown rehearsal
This scheme’s worst fall on file is about 32%. Before you SIP, ask whether you would keep contributing through a similar drop - pausing on fear is the usual India MF failure mode.
SIP discipline
Monitor is recent mixed evidence - keep the SIP unless the buying brief says prefer peers, then swap with intent.
NAV
29 Oct 2026 · -0.3% over 1Y
9.12
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
SIP XIRR
Equal monthly instalments to latest NAV
Date-aligned against NIFTY 500 TRI. Capture ratios use common month-end observations through 30 Oct 2026.
Peak to trough from a running NAV high, with the path and recovery episodes.
Drawdown
29 Oct 2026
-14.4%
31 Jul 2024 – open
Trough 3 Mar 2025 · not recovered
-32.2%
9 Jul 2024 – 29 Jul 2024
Trough 19 Jul 2024 · recovered in 10 days
-4.5%
18 Jun 2024 – 5 Jul 2024
Trough 28 Jun 2024 · recovered in 7 days
-2.3%
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
22
Vs category
76
Consistency
10
Risk-adjusted
1
Drawdown
20
Mean
26
Quantitative engine reasons behind the buying stance. An explanation can only restate what is already here.
Buying stance
Watch before adding
Recent evidence is mixed. Compare peers before increasing exposure.
Why this status
Supporting reads
No supporting reads in the current evidence set.
30 Sept 2026 · 50 holdings · top 10 are 37.9%.
Sterlite Technologies Ltd
Technology
6.5%
Religare Enterprises Ltd
Financial
6.4%
MTAR Technologies Ltd
Industrials
3.9%
Shilpa Medicare Ltd
Healthcare
3.5%
Laurus Labs Ltd
Healthcare
3.3%